Article

Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease.

Division of Nuclear Medicine, 110 Donner Building, H.U.P., 3400 Spruce Street, Philadelphia, PA, 19104, USA.
European journal of nuclear medicine and molecular imaging (Impact Factor: 5.11). 03/2005; 32(3):302-7. DOI: 10.1007/s00259-004-1667-x
Source: PubMed

ABSTRACT Multiple system atrophy (MSA), a disorder causing autonomic dysfunction, parkinsonism, and cerebellar dysfunction, is difficult to differentiate from other movement disorders, particularly early in the course of disease. This study evaluated whether [99mTc]TRODAT-1 binding to the dopamine transporter differentiates MSA from other movement disorders.
Single-photon emission computed tomographic brain scans were acquired in 25 MSA patients, 48 age-matched controls, and 130 PD patients, 3 h after the injection of 740 MBq (20 mCi) of [99mTc]TRODAT-1. Regions of interest (ROIs) were placed manually on subregions of both basal ganglia and distribution volume ratios (DVRs) were calculated. Regional DVRs were compared between study groups in MSA patients. Student's t tests were used to compare MSA patients with other study groups. Spearman correlations were used to compare DVRs with NP measures.
Based upon various motor scores, MSA and PD patients had comparable motor impairment, and were significantly impaired compared with controls. Mean DVRs in the basal ganglia of MSA patients were significantly less than those of controls, but generally higher (p<0.05) than in PD patients. In particular, the MSA patients had significantly increased DVRs in the posterior putamen (mean 0.49+/-0.30) compared with PD patients (0.74+/-0.25).
Movement disorder patients could be differentiated from controls, but MSA and PD patients could not be easily differentiated from each other. As a group, MSA patients had significantly higher mean [99mTc]TRODAT-1 binding, particularly in the posterior putamen, compared with PD patients and significantly lower binding compared with controls. This may reflect different pathophysiological processes of the two neurodegenerative diseases.

0 Bookmarks
 · 
105 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Research relevant to the creation and development of luxury brands is a growing area in the literature. Offering insight, previous research also contributes evidence of a lack of clarity regarding a definition, operationalization, and measurement of brand luxury. This study focuses specifically on this issue within the pre-eminent luxury fashion brands category. Carefully examining brand luxury and the dimensions and relationships underlying the luxury fashion brand, this study develops a conceptual model. Testing across three specific fashion categories the Brand Luxury Model makes important contributions, by clarifying the confusion evident in earlier brand luxury research, supplying evidence about the importance of brand leadership, and helping brand managers and academics by creating a useful framework to depict the luxury fashion brand.
    Journal of Business Research - J BUS RES. 10/2012;
  • [Show abstract] [Hide abstract]
    ABSTRACT: To provide a convenient and facile method to evaluate the radiochemical purity (RCP) of 99mTc-TRODAT-1 in quality control of routine clinical application, a simplified method of single-strip thin layer chromatography To provide a convenient and facile method to evaluate the radiochemical purity (RCP) of 99mTc-TRODAT-1 in quality control of routine clinical application, a simplified method of single-strip thin layer chromatography (TLC) was developed and validated by high performance liquid chromatography (HPLC). The RCP data of TLC correlated well with (TLC) was developed and validated by high performance liquid chromatography (HPLC). The RCP data of TLC correlated well with HPLC. HPLC.
    Journal of Radioanalytical and Nuclear Chemistry 08/2008; 277(3):591-594. · 1.41 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Parkinson's disease (PD) is a common disorder, and the diagnosis of Parkinson's disease is clinical and relies on the presence of characteristic motor symptoms. The accuracy of the clinical diagnosis of PD is still limited. Functional neuroimaging using SPECT technique is helpful in patients with first signs of parkinsonism. The changes detected may reflect the disease process itself and/or compensatory responses to the disease, or they may arise in association with disease- and/or treatment-related complications. This paper addresses the value of SPECT in early differential diagnosis of PD and its potential as a sensitive tool to assess the pathophysiology and progression, as well as the therapeutic efficacy of PD.
    BioMed Research International 01/2012; 2012:412486. · 2.71 Impact Factor

Full-text (2 Sources)

Download
23 Downloads
Available from
May 27, 2014